摘要:专注罕见病药物研发的 Disc 公司,在核心药物遭 FDA 拒批后,做出了裁员 20 人的决定。这波操作看似是断臂求生,实则是企业试图在行业寒冬里稳住发展节奏的选择,只是这步棋,走得不算轻松。
Synergy Spine Solutions has received premarket approval (PMA) from the US Food and Drug Administration (FDA) for the Synergy ...
Disc Medicine develops therapies for rare blood disorders, leveraging clinical-stage biotech expertise in red blood cell biology.
A hardware feature that used to be standard on computers and consoles has quietly disappeared. Several practical shifts explain why it stopped mattering.
Disc Medicine is laying off a fifth of its workforce as the biotech reels from the FDA’s rejection of its rare blood disease candidate. | Disc Medicine is laying off a fifth of its workforce as the ...
Electric bicycles are a popular means of transportation that combine the advantages of traditional bikes with the benefits of modern technology to provide a gentle (or sometimes powerful) boost to the ...
The PlayStation 5 is finally easy to find after years of scarcity, but before you hit that “add to cart” button, you’ll still have to make an important decision: PS5 Disc or PS5 Digital Edition? And ...
Low back pain is the main cause of disability worldwide and imposes an enormous clinical and socioeconomic burden on society. 1 Although numerous potential causes are recognized, the condition is ...